Company page
Aptabio Therapeutics, Inc.
Aptabio Therapeutics, Inc. is a public company listed under the ticker 293780 on the Korean market. The company has a market capitalization of approximately 117.32 million. Aptabio focuses on developing innovative therapeutic solutions.
- Ticker
- 293780
- Market cap
- $117.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major